BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17314595)

  • 1. Serendipitous detection of testicular seminoma on F-18 FDG positron tomography.
    Ali I; Johns W; Bottger B; Gupta SM
    Clin Nucl Med; 2007 Mar; 32(3):201-2. PubMed ID: 17314595
    [No Abstract]   [Full Text] [Related]  

  • 2. False-positive finding in FDG-PET in a patient with seminoma and sarcoidosis.
    Liepe K
    Acta Clin Belg; 2015 Apr; 70(2):138-40. PubMed ID: 25409626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: 18F-FDG PET/CT Impact on Testicular Tumours Clinical Management.
    Richie JP
    J Urol; 2015 Oct; 194(4):991. PubMed ID: 26382779
    [No Abstract]   [Full Text] [Related]  

  • 4. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in urological cancers].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S80-7. PubMed ID: 12739339
    [No Abstract]   [Full Text] [Related]  

  • 5. Diffuse splenic metastases from seminoma visualized on FDG PET.
    Lenzo NP; Moschilla G; Patrikeos A
    AJR Am J Roentgenol; 2004 Aug; 183(2):525-7. PubMed ID: 15269051
    [No Abstract]   [Full Text] [Related]  

  • 6. 2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial.
    De Santis M; Becherer A; Bokemeyer C; Stoiber F; Oechsle K; Sellner F; Lang A; Kletter K; Dohmen BM; Dittrich C; Pont J
    J Clin Oncol; 2004 Mar; 22(6):1034-9. PubMed ID: 15020605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma.
    De Santis M; Bokemeyer C; Becherer A; Stoiber F; Oechsle K; Kletter K; Dohmen BM; Dittrich C; Pont J
    J Clin Oncol; 2001 Sep; 19(17):3740-4. PubMed ID: 11533096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fluorodeoxyglucose (FDO) positron emission tomography (PET) in testicular germ cell tumors in adults: preliminary French clinical evaluation, development of the technique and its clinical applications].
    Maszelin P; Lumbroso J; Theodore C; Foehrenbach H; Merlet P; Syrota A
    Prog Urol; 2000 Dec; 10(6):1190-9. PubMed ID: 11217558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse.
    Hain SF; O'Doherty MJ; Timothy AR; Leslie MD; Harper PG; Huddart RA
    Br J Cancer; 2000 Oct; 83(7):863-9. PubMed ID: 10970686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pitfall of 18-fluorodeoxyglucose-PET in a patient with a tattoo.
    Nam H; Smith S; Laing R
    Lancet Oncol; 2007 Dec; 8(12):1147-1148. PubMed ID: 18054884
    [No Abstract]   [Full Text] [Related]  

  • 11. FDG PET/CT Image of Seminoma in Androgen Insensitivity Syndrome.
    Han EJ; O JH; Park G; Lee J
    Clin Nucl Med; 2017 Aug; 42(8):e381-e382. PubMed ID: 28604478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of fluorodeoxyglucose positron emission tomography scans in patients with advanced germ cell tumour following chemotherapy: single-centre experience with long-term follow up.
    Karapetis CS; Strickland AH; Yip D; Steer C; Harper PG
    Intern Med J; 2003; 33(9-10):427-35. PubMed ID: 14511195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET/CT with unusual bone and CNS metastases from testicular seminoma.
    Gómez FJ; Bánez IA; González RL; Jiménez-Granero P; Dorado IB
    Int Braz J Urol; 2015; 41(2):393-4. PubMed ID: 26005986
    [No Abstract]   [Full Text] [Related]  

  • 14. [Positron emission tomography in the investigation of malignant testicular tumors].
    Kálvin B; Márián T; Galuska L; Szakáll S; Géczi L; Esik O; Trón L; Bodrogi I
    Orv Hetil; 2002 May; 143(21 Suppl 3):1286-9. PubMed ID: 12077918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidental Finding of Testicular Seminoma by 18F-Choline PET/CT in a Prostate Cancer Patient.
    Calabrò A; Bosio G; Drera E; Giubbini R; Bertagna F
    Clin Nucl Med; 2022 Mar; 47(3):e249-e251. PubMed ID: 35020653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seminoma and sarcoidosis: a cause for false positive mediastinal uptake in PET?
    Muggia FM; Conti PS
    Ann Oncol; 1998 Aug; 9(8):924. PubMed ID: 9789621
    [No Abstract]   [Full Text] [Related]  

  • 17. Late relapse of testicular seminoma in the posterior mediastinum.
    Shin DJ; Kim JS; Kim DY; Yeo JS
    Clin Imaging; 2013; 37(2):406-8. PubMed ID: 23466004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caval seminoma thrombus on FDG PET/CT.
    Koc K; Aras M; Inanir S
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):64-5. PubMed ID: 24589250
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolated metastasis of testicular seminoma to extralobar pulmonary sequestration.
    Fudulu D; Casali G; Sohail M; Krishnadas R
    Asian Cardiovasc Thorac Ann; 2016 May; 24(4):386-8. PubMed ID: 26744493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG PET for detection and therapy control of metastatic germ cell tumor.
    Cremerius U; Effert PJ; Adam G; Sabri O; Zimmy M; Wagenknecht G; Jakse G; Buell U
    J Nucl Med; 1998 May; 39(5):815-22. PubMed ID: 9591582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.